SCHEMBL667406

SCHEMBL667406

O=C(O)COc1ccc2ccc3cccc4ccc1c2c34

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.63
ALDH1A1 P00352 3/20 0.63
HPGD P15428 3/20 0.63
TDP1 Q9NUW8 2/20 0.63
KMT2A Q03164 3/20 0.54
MEN1 O00255 1/20 0.54
GLA P06280 2/20 0.50
POLB P06746 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
HSD17B10 Q99714 1/20 0.50
PTPN7 P35236 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CTSD P07339 1/20 0.44
ALOX15 P16050 1/20 0.43
PTGDR2 Q9Y5Y4 2/20 0.42
OGG1 O15527 1/20 0.42
MAPT P10636 1/20 0.41
MTNR1A P48039 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29440259 1.00 KDM4E (0.63) KDM4EALDH1A1HPGDTDP1KMT2A
SCHEMBL28892041 0.85 HPGD (0.47) KDM4EALDH1A1HPGDTDP1KMT2A
SCHEMBL19999165 0.81 KMT2A (0.42) KDM4EALDH1A1HPGDTDP1KMT2A
SCHEMBL8582601 0.81 OGG1 (0.67) KDM4EALDH1A1HPGDTDP1KMT2A
SCHEMBL21969520 0.81 PTGDR2 (0.53) KDM4EALDH1A1HPGDTDP1KMT2A
SCHEMBL23512650 0.80 HPGD (0.43) KDM4EALDH1A1HPGDTDP1KMT2A
SCHEMBL10051547 0.80 TDP1 (0.44) KDM4EALDH1A1HPGDTDP1KMT2A
SCHEMBL29968561 0.79 ALDH1A1 (0.44) KDM4EALDH1A1HPGDTDP1KMT2A
SCHEMBL28892006 0.79 ALDH1A1 (0.44) KDM4EALDH1A1HPGDTDP1KMT2A
Formaldehyde SCHEMBL28892005 0.78 KMT2A (0.44) KDM4EALDH1A1HPGDTDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9513284-B2 Pyrenyloxysulfonic acid fluorescent agents Life Technologies Corporation (US) 2016-12-06 US disclosed
US-20140193926-A1 PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS Life Technologies Corporation (US) 2014-07-10 US disclosed
US-8614294-B2 Pyrenyloxysulfonic acid fluorescent agents Life Technologies Corporation (US) 2013-12-24 US disclosed
US-20130079497-A1 PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS Life Technologies Corporation (US) 2013-03-28 US disclosed
US-8268886-B2 Pyrenyloxysulfonic acid fluorescent agents Life Technologies Corporation (US) 2012-09-18 US disclosed
US-20120045848-A1 PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS Life Technologies Corporation (US) 2012-02-23 US disclosed
US-8039642-B2 Pyrenyloxysulfonic acid fluorescent agents Life Technologies Corporation (US) 2011-10-18 US disclosed
US-20080032379-A1 PYRENYLOXYSULFONIC ACID FLURESCENT AGENTS INVITROGEN CORPORATION (US) 2008-02-07 US disclosed
WO-2005064336-A1 PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS MOLECULAR PROBES, INC. (US) 2005-07-14 WO disclosed
US-20050123935-A1 Pyrenyloxysulfonic acid fluorescent agents MOLECULAR PROBES, INC. 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120045848-A1 PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS NOP56, ANXA5, ANXA6 KDM4E 3397/4885ALDH1A1 939/4885HPGD 1450/4885
US-20130079497-A1 PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS NOP56, ANXA5, ANXA6 KDM4E 3397/4885ALDH1A1 939/4885HPGD 1450/4885
US-20080032379-A1 PYRENYLOXYSULFONIC ACID FLURESCENT AGENTS NOP56, ANXA5, PFAS KDM4E 3939/4885ALDH1A1 1070/4885HPGD 1450/4885
US-20050123935-A1 Pyrenyloxysulfonic acid fluorescent agents NOP56, ANXA5, ANXA6 KDM4E 3397/4885ALDH1A1 939/4885HPGD 1450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.